37.48
-0.45
(-1.19%)
Bei Börsenschluss: January 30 at 4:00:01 PM EST
37.05
-0.43
(-1.15%)
Vorbörslich: 8:14:20 AM EST
Insider
Insider-Daten werden ausschließlich aus Formular 3 und Formular 4 der SEC-Einreichungen der letzten 24 Monate bezogen.
Person oder Einheit | Letzte Transaktion | Datum | Aktienbesitz Stand Transaktionsdatum |
---|---|---|---|
CARTER JASON S Officer | Stock Award(Grant) | Nov 18, 2024 | 53,000 |
COMMODORE CAPITAL LP Beneficial Owner of more than 10% of a Class of Security | Sale | Jan 10, 2024 | -- |
CURLEY JOANNE Officer | Sale | Aug 21, 2023 | 26,962 |
ENRIGHT PATRICK G. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 6, 2023 | -- |
FORDYCE MARSHALL Chief Executive Officer | Sale | Jan 8, 2025 | 365,633 |
GRANT SEAN Chief Financial Officer | Sale | Apr 3, 2024 | -- |
KATABI MAHA Director | Sale | Mar 25, 2024 | -- |
LIN CELIA Officer | Sale | Aug 21, 2023 | 11,010 |
SEIDENBERG BETH C Director | Sale | Oct 28, 2024 | 135,565 |
YOUNG JOSEPH R Officer | Sale | May 16, 2024 | 51,206 |
Ähnliche Ticker
JANX Janux Therapeutics, Inc.
44.79
+5.36%
TARS Tarsus Pharmaceuticals, Inc.
51.74
-2.51%
MLTX MoonLake Immunotherapeutics
47.12
+2.30%
EWTX Edgewise Therapeutics, Inc.
28.00
-1.48%
CYTK Cytokinetics, Incorporated
49.97
+2.71%
TVTX Travere Therapeutics, Inc.
21.05
+2.93%
APGE Apogee Therapeutics, Inc.
42.50
+5.41%
SRRK Scholar Rock Holding Corporation
40.40
-5.08%
RVMD Revolution Medicines, Inc.
43.07
+5.25%
CRNX Crinetics Pharmaceuticals, Inc.
40.26
+2.23%